Cargando…

Age-dependent inverse correlations in CSF and plasma amyloid-β(1–42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice

Amyloid-β (Aβ) plays a critical role as a biomarker in Alzheimer’s disease (AD) diagnosis. In addition to its diagnostic potential in the brain, recent studies have suggested that changes of Aβ level in the plasma can possibly indicate AD onset. In this study, we found that plasma Aβ(1–42) concentra...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Soo Min, Lee, Sejin, Yang, Seung-Hoon, Kim, Hye Yun, Lee, Michael Jisoo, Kim, Hyunjin Vincent, Kim, Jiyoon, Baek, Seungyeop, Yun, Jin, Kim, Dohee, Kim, Yun Kyung, Cho, Yakdol, Woo, Jiwan, Kim, Tae Song, Kim, YoungSoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735736/
https://www.ncbi.nlm.nih.gov/pubmed/26830653
http://dx.doi.org/10.1038/srep20185
Descripción
Sumario:Amyloid-β (Aβ) plays a critical role as a biomarker in Alzheimer’s disease (AD) diagnosis. In addition to its diagnostic potential in the brain, recent studies have suggested that changes of Aβ level in the plasma can possibly indicate AD onset. In this study, we found that plasma Aβ(1–42) concentration increases with age, while the concentration of Aβ(1–42) in the cerebrospinal fluid (CSF) decreases in APP(swe), PS1(M146V) and Tau(P301L) transgenic (3xTg-AD) mice, if measurements were made before formation of ThS-positive plaques in the brain. Our data suggests that there is an inverse correlations between the plasma and CSF Aβ(1–42) levels until plaques form in transgenic mice’s brains and that the plasma Aβ concentration possesses the diagnostic potential as a biomarker for diagnosis of early AD stages.